{"summary":"Experienced early and late-stage drug development project manager in oncology and infectious disease, with strong strategic, leadership, team development, alliance management, and communication skills, and a focus on operational excellence. Experience developing and leading high-performing cross-functional global product teams to achieve key development, regulatory, and commercial milestones within approved timelines and budget. Former research scientist with experience in early drug discovery, a Master in Business Administration (MBA), and a Master in Science (MSc). Collaborative and organized professional who thrives in complex, ambiguous, and fast-paced settings. Proficient in Microsoft Office suite and PLANIT. Certified Project Management Professional (PMP).\n\nAdditional experience in public relations, social media strategy, and journalism.\nLanguages: English, Serbian, Croatian","lastName":"Cvitkovic","objectUrn":"urn:li:member:56362494","geoRegion":"Rockville, Maryland, United States","fullName":"Romana Cvitkovic","firstName":"Romana","currentPositions":[{"companyName":"AstraZeneca","description":"As head of the PMO, lead a team of future-focused program leaders dedicated to driving the organizational effectiveness of Oncology Medical through simplification, prioritization, and optimization to ensure the seamless delivery of the global to local medical strategy and support a large portfolio of oncology assets.","title":"Senior Director, Project Management Office, Oncology Medical","companyUrnResolutionResult":{"employeeCountRange":"10001+","headquarters":{"geographicArea":"Cambridgeshire","country":"United Kingdom","city":"Cambridge","postalCode":"CB2 0AA","line2":"Cambridge Biomedical Campus","line1":"1 Francis Crick Avenue"},"website":"http:\/\/www.astrazeneca.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/astrazeneca\/","industry":"Pharmaceutical Manufacturing"},"companyUrn":"urn:li:fs_salesCompany:1603","tenureAtCompany":{"numYears":4,"numMonths":10},"startedOn":{"month":1,"year":2024}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAANcBf4BBf--Y3RngX9ZPQG8qhJGVj0wOrc,NAME_SEARCH,3sgA)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1715214215616?e=1723075200&v=beta&t=-l7vw3Kcg7daF7toaSEr2HQwQAexKBRlAkj-Wq5yVVQ","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1715214215616?e=1723075200&v=beta&t=KluklIoYfa9BWedw9GABddjlmu6q1m2tWlc9Nxlr5tQ","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1715214215616?e=1723075200&v=beta&t=xHfaF7LRsPrRGf6-HysiJ28Cl_3Z-bDXnxUG13WWm58","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1715214215616?e=1723075200&v=beta&t=KtNDjNpnEyS4ORa-AEVyJSpSNqj1qe5xFMWZ7Bf404k","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E03AQEYJ_BDEDeJEA\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2023},"degree":"Master of Business Administration - MBA","eduId":724983433,"schoolUrn":"urn:li:fs_salesSchool:3640","school":"urn:li:fs_salesSchool:3640","schoolName":"University of Maryland - Robert H. Smith School of Business","startedOn":{"year":2021}},{"degree":"Master of Science (M.Sc.)","schoolUrn":"urn:li:fs_salesSchool:166810","eduId":126628298,"school":"urn:li:fs_salesSchool:166810","fieldsOfStudy":["Physiology and Biophysics"],"schoolName":"Virginia Commonwealth University"},{"degree":"B.S","schoolUrn":"urn:li:fs_salesSchool:4035","eduId":39132498,"school":"urn:li:fs_salesSchool:4035","fieldsOfStudy":["Biology"],"schoolName":"Brigham Young University"}],"skills":[{"numOfEndorsement":0,"name":"Clinical Trials"},{"numOfEndorsement":0,"name":"Budgeting"},{"numOfEndorsement":0,"name":"Pharmaceuticals"},{"numOfEndorsement":0,"name":"Defining Requirements"},{"numOfEndorsement":0,"name":"Coaching"},{"numOfEndorsement":9,"name":"Research"},{"numOfEndorsement":6,"name":"Biotechnology"},{"numOfEndorsement":8,"name":"Public Relations"},{"numOfEndorsement":5,"name":"Immunology"},{"numOfEndorsement":5,"name":"Journalism"},{"numOfEndorsement":5,"name":"Editing"},{"numOfEndorsement":3,"name":"Marketing"},{"numOfEndorsement":2,"name":"Cell Biology"},{"numOfEndorsement":1,"name":"Bacteriology"},{"numOfEndorsement":0,"name":"Marketing Communications"},{"numOfEndorsement":0,"name":"Project Management"}],"numOfConnections":1114,"patents":[],"headline":"Senior Director, Head of Project Management Office, Oncology Global Medical Affairs at AstraZeneca | MBA, MSc, PMP","courses":[],"certifications":[{"companyUrn":"urn:li:fs_salesCompany:11352","authority":"Project Management Institute","name":"Project Management Professional (PMP)","company":"urn:li:fs_salesCompany:11352","licenseNumber":"2559505","startedOn":{"month":4,"year":2019}}],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/romanac","organizations":[],"location":"Rockville, Maryland, United States","publications":[{"name":"Target-Agnostic Identification of Functional Monoclonal Antibodies Against Klebsiella pneumoniae Multimeric MrkA Fimbrial Subunit","publishedOn":{"month":6,"day":1,"year":2016},"publisher":"Journal of Infectious Diseases","url":"http:\/\/jid.oxfordjournals.org\/content\/213\/11\/1800.long","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAANcBf4BBf--Y3RngX9ZPQG8qhJGVj0wOrc,NAME_SEARCH,3sgA)"}]},{"publishedOn":{"month":1,"day":19,"year":2017},"description":"Novel Fc engineering via multiplication to manipulate and improve antibody therapeutics against the gram-negative bacterium Klebsiella pneumoniae.","url":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/19420862.2017.1281505","name":"Enhancement of Antibody Functions Through Fc Multiplications","publisher":"mAbs","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAANcBf4BBf--Y3RngX9ZPQG8qhJGVj0wOrc,NAME_SEARCH,3sgA)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAAABz6qoBCqyCARdFOIeytsFO50QeTNH5440,NAME_SEARCH,QQbT)"},{"entityUrn":"urn:li:fs_salesProfile:(ACwAABXGMI4Be5cGH-zb0aNmGZDSRqX7Z6fG_Xg,NAME_SEARCH,_Vbr)"}]},{"name":"Anti-MrkA Monoclonal Antibodies Reveal Distinct Structural and Antigenic Features of MrkA","publishedOn":{"month":1,"day":20,"year":2017},"publisher":"PLoS One","url":"http:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0170529","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAANcBf4BBf--Y3RngX9ZPQG8qhJGVj0wOrc,NAME_SEARCH,3sgA)"}]},{"name":"Anti-LPS Antibodies Protect Against Klebsiella pneumoniae by Empowering Neutrophil-mediated Clearance without Neutralizing TLR4","publishedOn":{"month":5,"year":2017},"publisher":"JCI Insight","url":"https:\/\/insight.jci.org\/articles\/view\/92774","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAANcBf4BBf--Y3RngX9ZPQG8qhJGVj0wOrc,NAME_SEARCH,3sgA)"}]},{"name":"Immune Stealth-Driven O2 Serotype Prevalence and Potential for Therapeutic Antibodies Against Multidrug Resistant Klebsiella Pneumoniae","publishedOn":{"month":12,"year":2017},"publisher":"Nature Communications","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAANcBf4BBf--Y3RngX9ZPQG8qhJGVj0wOrc,NAME_SEARCH,3sgA)"}]}],"positions":null,"posts":[{"createdAt":1712836020000,"insightId":"caee66d7-638b-4e96-a00a-430b69a8ce43","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":2}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7183081449862901760,7184155000548265984)","threadUrn":"urn:li:activity:7183081449862901760","reactionsCount":2,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Amazing news - congratulations Martha! \ud83d\udc4f\ud83c\udffc\ud83d\udc4f\ud83c\udffc"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7183081449862901760"}}},{"createdAt":1712835720000,"insightId":"82cfbdd2-39da-4b64-8bf4-bfcd5279b11b","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7183093594180755456,7184153899786719232)","threadUrn":"urn:li:ugcPost:7183093594180755456","reactionsCount":1,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations Josh!! Welcome to AZ! We are so happy and eager to have you join the team. You will continue to pave the path of opportunity for so many patients who need life-saving care. Excited to see the great impact you will have!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7183093594180755456"}}},{"createdAt":1709585700000,"insightId":"32edc2c5-ba13-4699-850c-1c959602ac7c","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7170420711239458816,7170522202537185281)","threadUrn":"urn:li:activity:7170420711239458816","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Congratulations Gaby!! Such amazing news! We are so fortunate to have you as a leader at AZ! \ud83d\udc4f\ud83c\udffc\ud83d\udc4f\ud83c\udffc"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7170420711239458816"}}}]}